abstract |
The invention provides methods that relate to a novel therapeutic strategy for the treatment of hematological malignancies and inflammatory diseases. In particular, the method comprises administration of a compound of formula A, n n n n n n n n n n n n wherein R is H, halo, or C1-C6 alkyl; R′ is C1-C6 alkyl; or n a pharmaceutically acceptable salt thereof; and n optionally a pharmaceutically acceptable excipient; and n one or more additional therapeutic agents optionally selected from the group consisting of bendamustine, rituximah, and ofatumumab. |